XML 32 R7.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Class A Common Stock
[2]
Total Snowflake Inc. Stockholders’ Equity
Common Stock
Class A Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Noncontrolling Interest
Beginning balance (in shares) at Jan. 31, 2022       312,377,000          
Beginning balance at Jan. 31, 2022 $ 5,049,045   $ 5,049,045 $ 31 $ 0 $ 6,984,669 $ (16,286) $ (1,919,369) $ 0
Beginning balance, treasury stock (in shares) at Jan. 31, 2022         0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares) 6,118,000     6,118,000          
Issuance of common stock upon exercise of stock options $ 39,743   39,743 $ 1   39,742      
Issuance of common stock under employee stock purchase plan (in shares)       286,000          
Issuance of common stock under employee stock purchase plan 40,931   40,931     40,931      
Issuance of common stock in connection with a business combination (in shares)       1,916,000          
Issuance of common stock in connection with a business combination 438,916   438,916     438,916      
Issuance of common stock in connection with a business combination subject to future vesting (in shares)       409,000          
Vesting of early exercised stock options 244   244     244      
Vesting of restricted stock units (in shares)       3,348,000          
Shares withheld related to net share settlement of equity awards (in shares)       (1,149,000)          
Shares withheld related to net share settlement of equity awards (184,702)   (184,702)     (184,702)      
Stock-based compensation 890,950   890,950     890,950      
Capital contributions from noncontrolling interest holders 13,000               13,000
Other comprehensive income (loss) (21,986)   (21,986)       (21,986)    
Net loss (797,526)   (796,705)         (796,705) (821)
Ending balance (in shares) at Jan. 31, 2023       323,305,000          
Ending balance at Jan. 31, 2023 $ 5,468,615   5,456,436 $ 32 $ 0 8,210,750 (38,272) (2,716,074) 12,179
Ending balance, treasury stock (in shares) at Jan. 31, 2023         0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares) 8,357,000     8,355,000          
Issuance of common stock upon exercise of stock options $ 57,163   57,163 $ 1   57,162      
Issuance of common stock under employee stock purchase plan (in shares)       516,000          
Issuance of common stock under employee stock purchase plan 61,234   61,234     61,234      
Issuance of common stock in connection with a business combination (in shares) [1]       896,000          
Issuance of common stock in connection with a business combination [1] 174,284   174,284     174,284      
Issuance of common stock in connection with a business combination subject to future vesting (in shares)       385,000          
Vesting of early exercised stock options 163   163     163      
Vesting of restricted stock units (in shares)       6,804,000          
Vesting of restricted stock units 0   0 $ 1   (1)      
Shares withheld related to net share settlement of equity awards (in shares)       (2,296,000)          
Shares withheld related to net share settlement of equity awards $ (387,596)   (387,596)     (387,596)      
Repurchases of common stock as treasury stock (in shares) (500,000)       (500,000)        
Repurchases of common stock as treasury stock $ (68,299)   (68,299)   $ (68,299)        
Repurchases and retirement of common stock, including transaction costs (in shares)       (3,512,000)          
Repurchases and retirement of common stock, including transaction costs $ (523,433)   (523,433)         (523,433)  
Reissuance of treasury stock upon settlement of equity awards (in shares) 8,000       8,000        
Reissuance of treasury stock upon settlement of equity awards $ 27   27   $ 1,159 (1,132)      
Stock-based compensation 1,216,374   1,216,374     1,216,374      
Other comprehensive income (loss) 30,052   30,052       30,052    
Net loss (837,990)   (836,097)         (836,097) (1,893)
Ending balance (in shares) at Jan. 31, 2024   333,961,000   334,453,000          
Ending balance at Jan. 31, 2024 $ 5,190,594   5,180,308 $ 34 $ (67,140) 9,331,238 (8,220) (4,075,604) 10,286
Ending balance, treasury stock (in shares) at Jan. 31, 2024 (492,000)       (492,000)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock options (in shares) 6,608,000     6,593,000          
Issuance of common stock upon exercise of stock options $ 44,697   44,697     44,697      
Issuance of common stock under employee stock purchase plan (in shares)       660,000          
Issuance of common stock under employee stock purchase plan 77,053   77,053     77,053      
Issuance of common stock in connection with a business combination (in shares)       513,000          
Issuance of common stock in connection with a business combination 87,706   87,706     87,706      
Issuance of common stock in connection with a business combination subject to future vesting (in shares)       445,000          
Cancellation of common stock issued in connection with business combinations (in shares)       (76,000)          
Cancellation of common stock in connection with business combination (67)   (67)     (67)      
Vesting of restricted stock units (in shares)       9,859,000          
Vesting of restricted stock units 0     $ 2   (2)      
Shares withheld related to net share settlement of equity awards (in shares)       (3,381,000)          
Shares withheld related to net share settlement of equity awards (489,555)   (489,555)     (489,555)      
Repurchases and retirement of common stock, including transaction costs (in shares)       (14,765,000)          
Repurchases and retirement of common stock, including transaction costs $ (1,932,333)   (1,932,333) $ (2)       (1,932,331)  
Reissuance of treasury stock upon settlement of equity awards (in shares) 56,000       56,000        
Reissuance of treasury stock upon settlement of equity awards $ 142   142   $ 7,635 (7,493)      
Purchases of capped calls related to convertible senior notes (195,500)   (195,500)     (195,500)      
Stock-based compensation 1,507,134   1,507,134     1,507,134      
Other comprehensive income (loss) 5,984   5,984       5,984    
Net loss (1,289,212)   (1,285,640)         (1,285,640) (3,572)
Ending balance (in shares) at Jan. 31, 2025   333,865,000   334,301,000          
Ending balance at Jan. 31, 2025 $ 3,006,643   $ 2,999,929 $ 34 $ (59,505) $ 10,355,211 $ (2,236) $ (7,293,575) $ 6,714
Ending balance, treasury stock (in shares) at Jan. 31, 2025 (436,000)       (436,000)        
[1] In connection with a business combination completed on December 20, 2023, the Company issued approximately 0.2 million shares of its Class A common stock to one of its wholly-owned subsidiaries, in exchange for a noncontrolling equity interest in the acquired company that was held by the subsidiary prior to this business combination. These shares were treated as treasury stock for accounting purposes as of January 31, 2024, and were subsequently transferred to the Company and retired during the fiscal year ended January 31, 2025. These shares are not reflected in the Company’s consolidated statements of stockholders’ equity. See Note 7, “Business Combinations,” and Note 12, “Equity,” for further details.
[2] In connection with a business combination completed on December 20, 2023, the Company issued approximately 0.2 million shares of its Class A common stock to one of its wholly-owned subsidiaries, in exchange for a noncontrolling equity interest in the acquired company that was held by the subsidiary prior to this business combination. These shares were treated as treasury stock for accounting purposes as of January 31, 2024, and were subsequently transferred to the Company and retired during the fiscal year ended January 31, 2025. These shares are not reflected in the Company’s consolidated balance sheets. See Note 7, “Business Combinations,” and Note 12, “Equity,” for further details.